NCT07509788

Brief Summary

The goal of this observational study is to learn how listening effort affects brain development and daily life in school-aged children (ages 6-18) who use cochlear implants (CIs), which are electronic devices surgically placed in the ear to help children with severe hearing loss hear sounds. The main questions it aims to answer are: Do children with CIs use more mental energy to listen than children with normal hearing, and does this extra effort slow their brain development over time? Does listening with two ears (bilateral CIs or a CI plus a hearing aid) reduce listening effort compared to listening with one ear only? How does listening effort affect children's ability to get along with others and adapt to daily life? Researchers will compare children with CIs to children with normal hearing to see if differences in listening effort lead to differences in cognitive development, social skills, and quality of life over 3 years. Participants will: Complete hearing tests to measure how well they understand speech in quiet and noisy settings Wear a functional near-infrared spectroscopy (fNIRS) headset and eye-tracking glasses during a short listening task (about 15-40 minutes) so researchers can measure brain activity and pupil size changes - these are safe, painless, and non-invasive ways to see how hard the brain is working to listen Take thinking and memory tests appropriate for their age Have a parent or guardian answer questions about their child's social skills and daily communication Return for the same set of tests at 1 year and 3 years after the first visit This study does not involve any new treatment or change to a child's current care. All children will continue their regular medical and rehabilitation plans. The study aims to enroll 360 children (120 with normal hearing and 240 with cochlear implants) at Guangdong Provincial People's Hospital in China. Results may help doctors better understand when children with CIs need extra support and how to improve rehabilitation strategies.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
360

participants targeted

Target at P75+ for all trials

Timeline
54mo left

Started Oct 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Oct 2025Oct 2030

Study Start

First participant enrolled

October 1, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 22, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 3, 2026

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2030

Last Updated

April 15, 2026

Status Verified

April 1, 2026

Enrollment Period

5 years

First QC Date

March 22, 2026

Last Update Submit

April 10, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Listening Effort level

    Listening effort is measured synchronously during listening tasks using a multimodal approach, including pupillometry metrics (peak pupil dilation and mean pupil dilation, expressed as percentage of dynamic range) and fNIRS cortical hemodynamic metrics (HbDiff activation levels in bilateral inferior frontal gyrus and superior temporal gyrus regions). For participants with bilateral listening devices (bilateral CIs or bimodal stimulation), listening effort is measured under both better-ear-only and binaural listening conditions. Assessed at baseline, 1-year follow-up, and 3-year follow-up.

    Baseline , 1 and 3 years.

  • Cognitive Function Assessment

    Cognitive function is assessed using the Wechsler Intelligence Scale for Children, Fourth Edition (WISC-IV), including four index scores - Verbal Comprehension, Perceptual Reasoning, Working Memory, and Processing Speed - as well as the Full-Scale Intelligence Quotient (FSIQ). Assessed at baseline, 1-year follow-up, and 3-year follow-up.

    Baseline , 1 and 3 years

Secondary Outcomes (3)

  • Speech Audiometry

    Baseline , 1 and 3 years.

  • Listening-Related Fatigue Assessment

    Baseline , 1 and 3 years.

  • Social Adaptability Assessment

    Baseline , 1 and 3 years

Other Outcomes (3)

  • Spectral and Temporal Resolution Tests

    Baseline , 1 and 3 years.

  • Resting-State Brain Functional Scanning

    Baseline , 1 and 3 years.

  • Speech Development Assessment

    Baseline , 1 and 3 years.

Study Arms (3)

normal-hearing controls

Children with normal hearing

unilateral listeners

Children with unilateral cochlear implantation

bilateral listeners

Children with bilateral cochlear implantation or bimodal stimulation-unilateral CI with a contralateral hearing aid

Interventions

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

We aim to recruit 360 participants aged 6-18 years, categorized into three groups: a normal-hearing (NH) control group, a unilateral listening group (unilateral cochlear implantation, UCI), and a bilateral listening group (comprising bilateral cochlear implantation or bimodal stimulation-unilateral CI with a contralateral hearing aid).

You may qualify if:

  • Aged 6-18 years
  • Normal vision, including corrected vision
  • Prelingual deafness with bilateral severe-to-profound sensorineural hearing loss, with unilateral or bilateral cochlear implantation
  • Good speech perception ability, with Categories of Auditory Performance-II (CAP-II) score of 5 or above
  • Cooperative with testing, with signed informed consent from parent or guardian
  • Aged 6-18 years
  • Normal vision, including corrected vision
  • Bilateral pure-tone average at 250, 500, 1000, 2000, and 4000 Hz of 30 dB HL or less
  • Cooperative with testing, with signed informed consent from parent or guardian

You may not qualify if:

  • Diagnosed neurological or psychiatric disorders
  • Absence of informed consent from parent or guardian
  • Other conditions deemed unsuitable for participation by the investigators

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangdong Provincial People's Hospital

Guangzhou, Guangdong, China

RECRUITING

MeSH Terms

Conditions

Hearing Loss, Sensorineural

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

March 22, 2026

First Posted

April 3, 2026

Study Start

October 1, 2025

Primary Completion (Estimated)

October 1, 2030

Study Completion (Estimated)

October 1, 2030

Last Updated

April 15, 2026

Record last verified: 2026-04

Locations